Based on the current knowledge in the field, we hypothesized that LSD1 could play a role in atherogenesis by acting as a key epigenetic regulator of atherosclerosis-related pathological processes, namely Nox up-regulation, oxidative alteration of macromolecules, and inflammation via inflammatory markers. The gene discussed is KDM1A; the disease is atherosclerosis.